PLAINSBORO, N.J., Sept. 3, 2024. The Lancet has published a new pooled, participant-level analysis of patients with heart failure with mildly reduced...

MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.

THURSDAY, Sept. 12, 2024 -- The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the...

Sulthiame may help prevent patients’ breathing from temporarily stopping, international research suggests

Finerenone is effective in decreasing the incidence of heart failure and cardiovascular mortality. This finding has been reported based on a...

Finerenone is effective in decreasing the incidence of heart failure and cardiovascular mortality. This finding has been reported based on a...

Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...

Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...

WEDNESDAY, Sept. 11, 2024 -- An experimental weight-loss pill appears to help people quickly shed pounds, a new study says. People who took the drug...

Pfizer’s experimental cancer weight loss drug helped patients regain weight in a mid-stage study giving fresh promise for the dangerous...